CrushSCI.com
150.1Average days
91Median days
29Fastest days
420Longest days
252025 publications

Paper Review Records

All Paper Review Records

14 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

336 days

Emerging biological drugs for the treatment of patients with metastatic HER2+ gastroesophageal adenocarcinomas

Authors
Jane E. Rogers; Ashley Horak; Alicia Kroll; Jaffer A. AjaniShow moreShow less
Affiliations
1. U.T. M.D. Anderson Cancer Center; 2. U.T.M.D. Anderson Cancer CenterShow moreShow less
Source PDF DOI Publisher page
195 days

At the forefront of gene-based therapies in Dravet syndrome

Authors
Antonella Riva; Sara Di Gioacchino; Greta Volpedo; Beatrice Risso; Antonella De Lillo; Federico Zara; Antonio Falace; Pasquale StrianoShow moreShow less
Affiliations
1. University of Genoa; 2. IRCCS Istituto “Giannina Gaslini”, Full Member of ERN EpiCAREShow moreShow less
Source PDF DOI Publisher page
29 days

σ 1 receptor agonists: the new trend or an emerging therapeutic option?

Authors
Tangui MauriceShow moreShow less
Affiliations
1. University of Montpellier, EPHE, INSERMShow moreShow less
Source PDF DOI Publisher page
236 days

Evaluating emerging amyloid-β centric drugs for the treatment of Alzheimer's disease

Authors
Madia Lozupone; Vittorio Dibello; Rodolfo Sardone; Roberta Zupo; Fabio Castellana; Ilaria Bortone; Luisa Lampignano; Michela Di Matteo; Giuseppe Moramarco; Flora Dellegrazie; Antonio Daniele; Vincenzo Solfrizzi; Francesco PanzaShow moreShow less
Affiliations
1. Local Health Authority of Bari; 2. University of Bari Aldo Moro; 3. University of Bari “Aldo Moro”; 4. University of Amsterdam and Vrije Universiteit Amsterdam; 5. Local Healthcare Authority of Taranto; 6. Local Healthcare Authority of Bari; 7. Catholic University of Sacred Heart; 8. IRCCS Fondazione Policlinico Universitario A. GemelliShow moreShow less
Source PDF DOI Publisher page
87 days

Obefazimod (ABX464) for moderate-to-severe Crohn’s disease: clinical development of a novel oral therapeutic approach

Authors
Sailish Honap; Axel Dignass; Vipul Jairath; Fernando Magro; Silvio Danese; Laurent Peyrin-BirouletShow moreShow less
Affiliations
1. St George’s University Hospitals NHS Foundation Trust; 2. King’s College London; 3. Goethe University; 4. Western University; 5. Faculdade de Medicina da Universidade do Porto; 6. IRCCS Ospedale San Raffaele; 7. McGill University Health CentreShow moreShow less
Source PDF DOI Publisher page
77 days

Emerging treatment options for chronic obstructive pulmonary disease: a look into 2026 and beyond

Authors
Carolyn J. Wang; Clarus Leung; Don D. SinShow moreShow less
Affiliations
1. St. Paul’s Hospital; 2. The University of Western Australia; 3. University of British ColumbiaShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does EXPERT OPINION ON EMERGING DRUGS take to review a manuscript?

As of 2026-11-19, CrushSCI has 14 complete review records for EXPERT OPINION ON EMERGING DRUGS. The fastest paper went from submission to acceptance in 29 days (σ 1 receptor agonists: the new trend or an emerging therapeutic option?, received 2026-05-28, accepted 2026-06-26); the slowest took 420 days. The average is 150.1 days and the median is 91 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.